Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

299

Participants

Timeline

Start Date

September 29, 2022

Primary Completion Date

February 5, 2024

Study Completion Date

February 20, 2024

Conditions
Uncomplicated Urinary Tract Infection
Interventions
DRUG

Pivmecillinam hydrochloride tablets

400mg tablet

DRUG

Fosfomycin Tromethamine Granules

3g/pack

Trial Locations (10)

100000

Beijing hospital, Beijing

210000

Jiangsu Provincial Hospital of Integrated Chinese and Western Medicine, Nanjing

250000

Qilu Hospital of Shandong University, Jinan

410000

Xiangya Humanity Rehabilitation hospital, Changsha

414000

Yueyang people's Hospital, Yueyang

417000

Loudi Central Hospital, Loudi

430000

Wuhan Central Hospital, Wuhan

510000

Zhujiang Hospital of Southern Medical University, Guangzhou

530000

Guangxi Zhuang Autonomous Region People's Hospital, Nanning

050000

The second hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

Benova (Tianjin) Innovative medicine Research Co., Ltd.

OTHER